Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Gynecology & Clinical Practices Volume 6 (2019), Article ID 6:IJGCP-150, 6 pages
http://dx.doi.org/10.15344/2394-4986/2019/150
Original Article
Special Issue: Gynecology & Surgical Oncology
Impact of Neoadjuvant Chemotherapy in Patients with Advanced Stage (stage IIIC/IV) Endometrial Cancer: Single Institution Retrospective Analyses of Surgical and Survival Outcomes

Savithri Rajkumar1, Rahul Nath1, Geoffrey Lane1, Ahmad Sayasneh1, Gautam Mehra1, Vinod Mullassery1, Paul Seed2 and Anna Winship1,*

1Department of Gynaecological Oncology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), Westminster Bridge Road, London, UK
2Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, UK
Dr. Anna Winship, Department of Gynaecological Oncology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), Westminster Bridge Road, London, SE1 7EH, UK; E-mail: anna.winship@gstt.nhs.uk; E-mail: anna.winship@gstt.nhs.uk
20 January 2019; 18 December 2019; 20 December 2019
Rajkumar S, Nath R, Lane G, Sayasneh A, Mehra G, et al. (2019) Impact of Neoadjuvant Chemotherapy in Patients with Advanced Stage (stage IIIC/IV) Endometrial Cancer: Single Institution Retrospective Analyses of Surgical and Survival Outcomes. Int J Gynecol Clin Pract 6: 150. https://doi.org/10.15344/2394-4986/2019/150
© 2019 Rajkumar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Amant F, Moerman P, Neven P, Timmerman D, Limbergen EV, et al. (2005) Endometrial cancer. Lancet 366: 491-505. View
  2. Rose PG (1996) Endometrial Carcinoma. N Engl J Med 335: 640-649. View
  3. Bristow RE, Duska LR, Montz FJ (2001) The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Gynecol Oncol 81: 92-99. View
  4. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ, et al. (2000) Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78: 85-91. View
  5. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, et al. (2007) Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol 107: 190-193. View
  6. Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, et al. (2010) Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol 119: 299-304. View
  7. Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, et al. (2010) Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. N Engl J Med 363: 943-953. View
  8. Vandenput I, Van Calster B, Capoen A, K Leunen, P Berteloot, et al. (2009) Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Br J Cancer 101: 244-259. View
  9. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, et al. (2009) New response evaluation critria in solid tumours: revised RECIST guideline (version1.1). Eur J Cancer 45: 228-247. View
  10. SCsfEc (2014) SEER Cancer statistics factsheets : Endometrial cancer 2014 National Cancer institue Bethesda.
  11. Rabinovich A (2016) Neo-adjuvant chemotherapy for advanced stage endometrial carcinoma: a glimmer of hope in select patients. Arch Gynecol Obstet 293: 47-53. View
  12. Resnik E, Taxy JB (1996) Neoadjuvant chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol 62: 123-127. View
  13. Wilkinson-Ryan I, Frolova AI, Liu J, Massad LS, Thaker PH, et al. (2015) Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Stage IV Uterine Serous Carcinoma. Int J Gynecol Cancer 25: 63-68. View
  14. Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, et al. (2013) Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol 129: 478-485. View
  15. Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, et al. (2011) Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic Oncology 122: 608-611. View
  16. Chi DS, Welshinger M, Venkatraman ES, Barakat RR (1997) The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol 67: 56-60. View
  17. Memarzadeh S, Holschneider CH, Bristow RE, Jones NL, Fu YS, et al. (2002) FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer 12: 454-458. View
  18. Barlin JN, Puri I, Bristow RE (2010) Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol 118: 14-18. View
  19. Goldfinger M, Diaz I, Muggia F (2014) Systemic Treatment of Endometrial Cancer: What Is Doxorubicin's Role? Journal of Clinical Oncology 32: 2181- 2182. View
  20. Miller D, Filiaci V, Flemming G, Mannel R, Cohn D, et al. (2012) Randomized phase III noninferiority trial of first line chemotherapy for metastatic and recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
  21. Eto T, Saito T, Shimokawa M, Hatae M, Takeshima N, et al. (2013) Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: A retrospective multi-institutional study of 426 patients in Japan. Gynecol Oncol 131: 574-580. View
  22. Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, et al. (2017) BGCS uterine cancer guidelines: Recommendations for practice. Eur J Obstet Gynecol Reprod Biol 213: 71-97. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.